Expression of tumor-associated antigen RCAS1 and its possible involvement in immune evasion in oral squamous cell carcinoma

J Oral Pathol Med. 2006 Jul;35(6):361-8. doi: 10.1111/j.1600-0714.2006.00442.x.

Abstract

Background: RCAS1 (receptor-binding cancer antigen expressed on SiSo cells) is known to induce apoptosis in its receptor-positive cells. The authors investigated RCAS1 expression in oral squamous cell carcinoma (SCC) and its association with the apoptosis of tumor-infiltrating lymphocytes (TILs).

Methods: In 130 patients with oral SCC, the expression of RCAS1 in tumor cells was immunohistochemically examined and the apoptosis of TILs was examined by Terminal Deoxynucleotidyltransferase-mediated dUTP Nick End Labeling (TUNEL) staining.

Results: RCAS1 was detected both on the cytoplasm and the membrane of tumor cells in 41 of 130 cases (31.5%). Focusing on the expression at the invasive front interacting with host immune cells, RCAS1 was detected in 22 of 130 cases (16.9%). The percentage of TUNEL-positive TILs in cases with RCAS1-positive SCCs was significantly higher than in cases with RCAS1-negative SCCs (P < 0.0001).

Conclusions: RCAS1 can be expressed on oral SCC cells and may be involved in the tumor escape from the host immune system by inducing the apoptosis of TILs.

MeSH terms

  • Aged
  • Antigens, Neoplasm / biosynthesis*
  • Antigens, Neoplasm / physiology*
  • Apoptosis
  • Carcinoma, Squamous Cell / immunology*
  • Chi-Square Distribution
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Immunologic Surveillance
  • In Situ Nick-End Labeling
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Male
  • Middle Aged
  • Mouth Neoplasms / immunology*
  • Prognosis
  • Statistics, Nonparametric
  • Tumor Escape / immunology*

Substances

  • Antigens, Neoplasm
  • EBAG9 protein, human